CPC A61B 5/24 (2021.01) [A61B 5/389 (2021.01); A61B 5/394 (2021.01); A61B 5/4035 (2013.01); A61B 5/4041 (2013.01); A61B 5/6847 (2013.01); A61B 5/7475 (2013.01); A61N 1/00 (2013.01); A61N 1/36017 (2013.01); A61B 5/4893 (2013.01); A61B 5/6852 (2013.01); A61B 2018/0066 (2013.01); A61B 2018/00839 (2013.01); A61B 2018/0091 (2013.01); A61B 2018/00916 (2013.01); A61B 2018/0094 (2013.01); A61B 18/1442 (2013.01); A61B 2018/1452 (2013.01); A61B 2018/146 (2013.01); A61B 2562/225 (2013.01)] | 18 Claims |
1. A stimulation monitoring system to stimulate at least a portion of a patient with a stimulation instrument, comprising:
a monitoring assembly configured to be positioned in a non-sterile field, the monitoring assembly configured to generate a stimulation voltage;
a remote controller configured to be conductively connected to a handle of the stimulation instrument and configured to be positioned within a sterile field adjacent the patient; and
a conductor physically connected to the monitoring assembly and the remote controller;
wherein the remote controller includes an input to remotely control at least one operation of the monitoring assembly;
wherein the conductor is connected between the stimulation instrument and the remote controller and between the remote controller and the monitoring assembly, wherein the remote controller is configured to be spaced apart from the stimulation instrument but adjacent the patient;
wherein the remote controller is configured to enable the remote controller to be carried in the sterile field;
wherein the remote controller is configured to be removably and rigidly connected to the handle of the stimulation instrument and carried by the stimulation instrument.
|